EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Aptamer-Based Targeting of Cancer: A Powerful Tool for Diagnostic and Therapeutic Aims

Arash Mohammadinejad, Laura Elena Gaman iD, Ghazaleh Aleyaghoob, Liviu Gaceu iD, Seyed Ahmad Mohajeri, Marius Alexandru Moga, Mihaela Badea iD

Biosensors · 31.01.2024 · 14 (2) · 78

DOI: 10.3390/bios14020078 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 31.01.2024. Verfasst von Arash Mohammadinejad und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Fundamental, Prophylactic and Clinical Disciplines, Faculty of Medicine, Transilvania University of Brasov, 500019 Brașov, Romania. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Neoplasms, Nanostructures. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy Carol Davila.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is known as one of the most significant causes of death worldwide, and, in spite of novel therapeutic methods, continues to cause a considerable number of deaths. Targeted molecular diagnosis and therapy using aptamers with high affinity have become popular techniques for pathological angiogenesis and cancer therapy scientists. In this paper, several aptamer-based diagnostic and therapeutic techniques such as aptamer–nanomaterial conjugation, aptamer–drug conjugation (physically or covalently), and biosensors, which have been successfully designed for biomarkers, were critically reviewed. The results demonstrated that aptamers can potentially be incorporated with targeted delivery systems and biosensors for the detection of biomarkers expressed by cancer cells. Aptamer-based therapeutic and diagnostic methods, representing the main field of medical sciences, possess high potential for use in cancer therapy, pathological angiogenesis, and improvement of community health. The clinical use of aptamers is limited due to target impurities, inaccuracy in the systematic evolution of ligands via exponential enrichment (SELEX)stage process, and in vitro synthesis, making them unreliable and leading to lower selectivity for in vivo targets. Moreover, size, behavior, probable toxicity, low distribution, and the unpredictable behavior of nanomaterials in in vivo media make their usage in clinical assays critical. This review is helpful for the implementation of aptamer-based therapies which are effective and applicable for clinical use and the design of future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideNeoplasmsNanostructuresHumansDrug Delivery SystemsBiomarkers

Stichwörter der Autor:innen

aptamerbiosensorcancerdiagnosistherapy

Substanzen

Aptamers, NucleotideBiomarkers

Autor:innen und Institutionen

  • Department of Fundamental, Prophylactic and Clinical Disciplines, Faculty of Medicine, Transilvania University of Brasov, 500019 Brașov, Romania.
  • Research Center for Fundamental Research and Prevention Strategies in Medicine, Research and Development Institute of Transilvania University of Brasov, 500484 Brașov, Romania.
  • Faculty of Medicine, University of Medicine and Pharmacy "Carol Davila", 020021 Bucharest, Romania.
  • Department of Medical Biotechnology and Nanotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.
  • Department of Chemistry, Payame Noor University, Tehran 19395-4697, Iran.
  • Faculty of Food and Tourism, Transilvania University of Brasov, 500014 Brașov, Romania.

ORCID-Profile: Laura Elena Gaman, Liviu Gaceu, Mihaela Badea

Förderung

  • University of Medicine and Pharmacy Carol Davila

Zitieren

APA

Mohammadinejad, A., Gaman, L. E., Aleyaghoob, G., Gaceu, L., Mohajeri, S. A., Moga, M. A., & Badea, M. (2024). Aptamer-Based Targeting of Cancer: A Powerful Tool for Diagnostic and Therapeutic Aims. Biosensors, 14(2), 78. https://doi.org/10.3390/bios14020078

Vancouver

Mohammadinejad A, Gaman LE, Aleyaghoob G, Gaceu L, Mohajeri SA, Moga MA, et al. Aptamer-Based Targeting of Cancer: A Powerful Tool for Diagnostic and Therapeutic Aims. Biosensors. 2024;14(2):78. doi:10.3390/bios14020078

BibTeX
@article{Mohammadinejad2024,
  author = {Mohammadinejad, Arash and Gaman, Laura Elena and Aleyaghoob, Ghazaleh and Gaceu, Liviu and Mohajeri, Seyed Ahmad and Moga, Marius Alexandru and Badea, Mihaela},
  title = {Aptamer-Based Targeting of Cancer: A Powerful Tool for Diagnostic and Therapeutic Aims},
  journal = {Biosensors},
  year = {2024},
  volume = {14},
  number = {2},
  pages = {78},
  doi = {10.3390/bios14020078}
}
Kostenlos starten →